Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients
Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients have?
Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients has 232 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients published?
Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients has 2012 year in the ScholarIQ index.
What is the open-access status of Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients?
Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients has green oa status in the ScholarIQ index.
What is the DOI of Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients?
The DOI for Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients is on the source record.
What is the PMID of Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients?
The PMID for Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients is on the source record.
What is the OpenAlex record for Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients?
The OpenAlex for Treatment of Refractory Uveitis with Adalimumab: A Prospective Multicenter Study of 131 Patients is on the source record.